Eipico

Eipico, established in 1980, stands as the foremost pharmaceutical company in Egypt. Specializing in the production of critical medical supplies including antibiotics, lyophilized products, and spansule capsules, Eipico is dedicated to delivering high-quality pharmaceutical solutions at accessible price points. This commitment directly supports the enhancement of global human healthcare standards. The company has solidified its position as a key player within the Egyptian pharmaceutical landscape, demonstrating consistent growth and market penetration since its inception.

Operating with a workforce of 5,000-10,000 employees across its 2 locations, Eipico maintains a robust operational footprint. The company's influence extends globally through significant exports to diverse regions such as Europe, Africa, and Latin America. Eipico is actively driving pharmaceutical sector innovation by localizing the manufacturing of biological and biosimilar products at its advanced EIPICO 3 facility. To understand the driving force behind these advancements, one can learn more about the dedicated professionals by visiting Meet Eipico's team.

Eipico commands a substantial 29% share of the total Egyptian pharmaceutical export market by value, underscoring its international competitiveness and product demand. The company's strategic focus on innovation, particularly in biological and biosimilar manufacturing, positions it at the forefront of pharmaceutical development. Through its state-of-the-art facilities and unwavering commitment to quality and affordability, Eipico continues to make significant contributions to healthcare accessibility and advancement both domestically and internationally.